Today: 30 April 2026
Synchrony Financial stock slides on Trump’s 10% credit-card rate cap push — what to know now
12 January 2026
1 min read

Synchrony Financial stock slides on Trump’s 10% credit-card rate cap push — what to know now

NEW YORK, Jan 12, 2026, 09:51 EST — Regular session

  • Synchrony Financial shares fell about 7% in early trade as credit-card lenders sold off.
  • President Donald Trump called for a one-year 10% cap on credit-card interest rates starting Jan. 20.
  • Investors are watching whether the idea turns into legislation as bank earnings season begins.

Synchrony Financial shares were down about 7% at $80.80 on Monday morning, as investors sold credit-card lenders after President Donald Trump called for a one-year cap on credit-card interest rates.

The proposal matters for Synchrony because it leans heavily on interest income from store and co-branded cards. A hard cap would compress what lenders earn on revolving balances, just as the sector heads into a fresh earnings cycle.

Trump said on Friday he was calling for a 10% cap starting Jan. 20, but offered no details on how the plan would be enforced. “We will no longer let the American Public be ‘ripped off’ by Credit Card Companies,” he wrote on Truth Social. Reuters

Card-linked names across the market fell with Synchrony. Capital One slid about 6%, while American Express was down about 4%; Visa and Mastercard also traded lower, and the financial sector ETF lagged the broader market.

Analysts also flagged the knock-on effects for consumers. “This rate cap would not address the root of the problem and could push consumers towards more expensive debt,” J.P. Morgan analyst Vivek Juneja wrote, pointing to a shift toward non-bank lenders if banks pull back. Reuters

Jefferies analysts said the White House lacks the executive authority to impose such a cap on its own, calling it unlikely to survive Congress. That legal uncertainty is part of what traders are trying to price out in real time.

Still, the headline risk is enough to hit companies most exposed to card spreads. Bread Financial, another card-heavy lender, fell nearly 9% in early trading.

For Synchrony, the swing factor is whether the politics moves beyond a presidential call and into actual legislation. A rate cap would likely force lenders to tighten credit standards, cut credit lines or lift fees elsewhere — steps that can slow growth and push delinquencies around.

There is also a path where nothing happens. Previous efforts to cap credit-card rates have struggled to gain traction in Washington, and banks and industry groups have warned such a move could reduce credit availability and steer borrowers to costlier options.

Investors will look for signs of pushback — and how seriously executives take the threat — as big U.S. banks start reporting quarterly results this week, beginning with JPMorgan on Tuesday.

Synchrony’s next fixed catalyst is its fourth-quarter results on Jan. 27, when investors will listen for management’s read on pricing, credit trends and the policy backdrop.

Stock Market Today

  • Biogen Shares Rise 6% After Q1 Earnings Beat Despite Guidance Cut
    April 29, 2026, 9:29 PM EDT. Biogen (NASDAQ: BIIB) shares rose 6% on Wednesday following its first-quarter 2026 earnings report. The biotech posted $2.48 billion in revenue, surpassing analyst expectations of $2.25 billion. Net income, excluding accounting standards (GAAP), increased 19% to over $529 million, or $3.57 per share, above forecasts of $2.95. Growth was driven by strong sales of Leqembi, for early Alzheimer's, up 74%, and the FDA-approved Skyclarys for Friedreich's ataxia. However, Biogen cut full-year adjusted net income guidance by $1 per share citing research and development charges. Revenue is expected to decline mid-single digits from 2025, excluding a pending $5.6 billion acquisition of Apellis Pharmaceuticals. Biogen's strategic shift towards high-potential therapies is underway despite cautious outlook.

Latest article

Soluna Holdings Stock Jumps After Sazmining Bitcoin Deal, Then SEC Resale Filing Lands

Soluna Holdings Stock Jumps After Sazmining Bitcoin Deal, Then SEC Resale Filing Lands

30 April 2026
Soluna Holdings filed to register the resale of about 2.46 million common shares, with no proceeds going to the company. The move follows Sazmining’s launch of a 3-megawatt Bitcoin mining operation at Soluna’s Project Dorothy 1B in West Texas. Soluna shares last traded at $1.28, up from a $1.08 Nasdaq sale price on April 28. The registered shares include 2.4 million issuable to YA II PN, LTD. via warrant exercise.
Brookfield Renewable Stock Drops 12% Before Q1 Results as BEPC Investors Brace for Friday

Brookfield Renewable Stock Drops 12% Before Q1 Results as BEPC Investors Brace for Friday

30 April 2026
Brookfield Renewable Corp’s NYSE shares fell 12.5% to $35.20 on Wednesday, with volume quadrupling the three-month average ahead of first-quarter results due Friday. The drop came despite a higher quarterly dividend and mixed analyst views. The company operates 47 GW of clean energy assets globally. Analysts expect a first-quarter loss of 33.92 cents per share on $1.62 billion in revenue.
Citigroup stock slides as Trump’s 10% credit-card rate cap plan rattles lenders ahead of earnings
Previous Story

Citigroup stock slides as Trump’s 10% credit-card rate cap plan rattles lenders ahead of earnings

Klarna Group plc stock (KLAR) slides as Trump’s 10% credit-card cap talk jolts lenders, lawsuit deadline looms
Next Story

Klarna Group plc stock (KLAR) slides as Trump’s 10% credit-card cap talk jolts lenders, lawsuit deadline looms

Go toTop